Skip to main content

Advertisement

Table 3 The time interval from enrollment date to index date of each co-morbidity in the study group

From: Risk factors for the occurrence of visual-threatening posterior capsule opacification

  Time interval (months)
Mean (SD) Median (Q1, Q3)
All Nd:YAG capsulotomy 32.12 (31.19) 25 (7, 45)
Co-morbidities
 Corneal disease 26.32 (27.18) 20 (5, 37)
 DED 22.77 (22.65) 17 (5, 34)
 Glaucoma 26.71 (27.58) 19 (5, 38)
 Uveitis 21.03 (24.87) 13 (3, 30)
 AMD 23.31 (22.96) 16 (4, 36)
 Hypertension 28.02 (26.24) 22 (6, 41)
 DM 27.73 (27.17) 20 (6, 41)
 Hyperlipidemia 25.8 (24.71) 19 (5, 38)
 Congestive heart failure 26.55 (24.69) 20 (6, 41)
 Myocardial infarction 31.62 (30.11) 21 (6, 44)
 Cerebrovascular disease 27.47 (26.5) 20 (6, 39)
 Peripheral vascular disease 27.97 (27.38) 20 (6, 41)
 Dementia 24.3 (27.37) 14 (3, 35)
 Chronic pulmonary disease 29.14 (26.74) 23 (7, 43)
 Rheumatic disease 28.49 (24.5) 25 (8, 43)
 Peptic ulcer disease 28.28 (26.66) 22 (7, 41)
 Liver disease 28.71 (26.51) 23 (7, 42)
 Hemiplegia or paraplegia 24.53 (25.98) 16 (5, 37)
 Renal disease 26.22 (25.26) 20 (6, 39)
 Malignancy 25.7 (23.84) 20 (6, 39)
 Coagulation defects 34.92 (38.05) 22 (7, 51.5)
  1. SD standard deviation, DED dry eye disease, AMD age-related macular degeneration, DM diabetes mellitus